Drug Profile
MMS 1
Latest Information Update: 10 Sep 1998
Price :
$50
*
At a glance
- Originator International Gene Group
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 10 Sep 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 18 Jun 1996 New profile
- 18 Jun 1996 Preclinical development for HIV infections treatment in USA (Unknown route)